Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | SLC37A4 | O43826 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25220694 | 0.92 | POLB (0.42) | POLBSLC37A4ALDH1A1ALOX15KDM4E | |
| Water SCHEMBL27890364 | 0.90 | POLB (0.41) | POLBSLC37A4ALDH1A1ALOX15KDM4E | |
| SCHEMBL409572 | 0.90 | SLC37A4 (0.45) | POLBSLC37A4ALDH1A1ALOX15KDM4E | |
| SCHEMBL15281935 | 0.88 | SLC37A4 (0.41) | POLBSLC37A4ALDH1A1ALOX15KDM4E | |
| SCHEMBL990486 | 0.87 | POLB (0.46) | POLBSLC37A4ALDH1A1ALOX15KDM4E | |
| SCHEMBL1134750 | 0.86 | SLC37A4 (0.54) | POLBSLC37A4ALDH1A1KDM4EKMT2A | |
| SCHEMBL7942880 | 0.85 | SLC37A4 (0.53) | SLC37A4ALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL7944631 | 0.85 | SLC37A4 (0.53) | SLC37A4ALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL7942873 | 0.85 | SLC37A4 (0.53) | SLC37A4ALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL5695797 | 0.84 | POLB (0.44) | POLBSLC37A4ALDH1A1ALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368057-B1 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | TORREY PINES INST (US) | 2009-08-26 | — | — | EP | claimed |
| US-7229621-B2 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2007-06-12 | — | — | US | claimed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1071411-A4 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1368057-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | Lancell, Llc (US) | 2003-12-10 | — | — | EP | claimed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | claimed |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-09-27 | — | — | US | claimed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | claimed |
| EP-1071411-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2001-01-31 | — | — | EP | claimed |
| WO-1999053912-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-10-28 | — | — | WO | claimed |
| US-4829037-A | STEREOREGULAR POLYMER IN HIGH YIELD | TOHO TITANIUM CO., LTD. (JP) | 1989-05-09 | — | — | US | claimed |
| EP-0268685-A1 | CATALYST FOR POLYMERIZING OLEFINS | TOHO TITANIUM CO. LTD. (JP) | 1988-06-01 | — | — | EP | claimed |
| US-4562173-A | MAGNESIUM FATTY ACID SALT, MAGNESIUM CARBONATE COMPOUND, AROMATIC DICARBOXYLIC ACID ESTER, TITANIUM HALIDE, SILICON COMPOUND, ORGANOA | TOHO TITANIUM CO., LTD. (JP) | 1985-12-31 | — | — | US | claimed |
| US-4547476-A | COORDINATION CATALYST CONTAINING MAGNESIUM, TITANIUM, ALUMINUM ANDSILICON COMPOUNDS, AROMATIC ESTER AND HALOGENATED COMPOUNDS | TOHO TITANIUM CO., LTD. (JP) | 1985-10-15 | — | — | US | claimed |
| US-20150307938-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL L L C (US) | 2015-10-29 | — | — | US | disclosed |
| WO-2012138928-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL, L.L.C. (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120258125-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL, L.L.C. (US) | 2012-10-11 | — | — | US | disclosed |
| EP-0268685-A1 | CATALYST FOR POLYMERIZING OLEFINS | TOHO TITANIUM CO. LTD. (JP) | 1988-06-01 | — | — | EP | disclosed |
| US-4562173-A | MAGNESIUM FATTY ACID SALT, MAGNESIUM CARBONATE COMPOUND, AROMATIC DICARBOXYLIC ACID ESTER, TITANIUM HALIDE, SILICON COMPOUND, ORGANOA | TOHO TITANIUM CO., LTD. (JP) | 1985-12-31 | — | — | US | disclosed |
| US-4547476-A | COORDINATION CATALYST CONTAINING MAGNESIUM, TITANIUM, ALUMINUM ANDSILICON COMPOUNDS, AROMATIC ESTER AND HALOGENATED COMPOUNDS | TOHO TITANIUM CO., LTD. (JP) | 1985-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | CD69, CD74, LY96 | POLB 4204/4885SLC37A4 1656/4885ALDH1A1 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.